Abstract
The article describes the problems of the menopausal transition period that cause a woman significant discomfort and reduce her quality of life, characterizes the most common methods of treating menopausal syndrome, and suggests possible reasons for their lack of effectiveness. Femoklim, a fundamentally new anti-menopausal drug for the treatment of complications of age-related hormonal changes, is analyzed. It takes due regard to all possible mechanisms of the occurrence of menopausal syndrome, has a complex versatile effect on the female body, and does not provoke the development of cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
